Revenue: The sum of all revenue fields included for a company's operating activities.
China SXT Pharmaceuticals, Inc. (SXTC) had Revenue of $1.97M for the most recently reported fiscal year, ending 2023-03-31.
| Income Statement Financials | |
|
Revenue |
$1.97M |
$-5.93M |
|
$1.55M |
|
$0.43M |
|
$7.58M |
|
$-5.61M |
|
$-0.33M |
|
$-5.93M |
|
$-5.93M |
|
$-5.93M |
|
$-5.93M |
|
$-5.93M |
|
$-5.93M |
|
$-5.61M |
|
$-5.36M |
|
0.27M |
|
0.27M |
|
$-22.23 |
|
$-22.23 |
|
| Balance Sheet Financials | |
$19.52M |
|
$0.96M |
|
$10.03M |
|
$29.55M |
|
$14.50M |
|
$0.12M |
|
$0.37M |
|
$14.86M |
|
$14.69M |
|
$14.66M |
|
$14.69M |
|
0.46M |
|
| Cash Flow Statement Financials | |
$-0.08M |
|
$-0.01M |
|
$2.94M |
|
$15.57M |
|
$17.37M |
|
$1.80M |
|
$0.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.35 |
|
-- |
|
-- |
|
0.01 |
|
0.23 |
|
21.62% |
|
-284.40% |
|
-284.40% |
|
-271.71% |
|
-301.00% |
|
-301.00% |
|
$-0.15M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
2.91 |
|
1.47 |
|
248.91 |
|
-40.40% |
|
-40.47% |
|
-20.08% |
|
-40.08% |
|
$32.12 |
|
$-0.57 |
|
$-0.30 |
|